Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

May 23, 2023

Study Completion Date

September 30, 2024

Conditions

Liver Transplant Rejection

Interventions

DRUG

Erythropoietin

Trial Locations (1)

Northwestern University, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER

NCT05325073 - Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients | Biotech Hunter | Biotech Hunter